Protalix BioTherapeutics, Inc. (PLX) has 12 identified peers for comparison in the Healthcare sector. Peers include AKBA, ALDX, CDTX, CDXS, CHRS, CKPT and others.
PLX has a market capitalization of $190.15M, compared to an average peer market cap of $1.45B. PLX is notably smaller than its average peer.
